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CDK5RAP2a b s t r a c t
Background: Rheumatoid arthritis (RA) is known as a chronic autoimmune inflammatory disorder, which
is characterized mainly by the progressive inflammation and destruction of the joints. In the pathogenesis
of RA, a variety of cell types such as lymphocyte, dendritic cells, osteoclasts and synovial fibroblasts are
involved. Genetic proneness has been implicated in the pathogenesis of RA. The aim of this study was to
evaluate the association of single nucleotide polymorphisms (SNPs) in DPP4 and CDK5RAP2 genes and risk
of RA in Iranian population.
Methods: For genotyping, 623 RA patients and 412 healthy subjects were recruited. Genetic analysis of
DPP4 gene rs12617656 and CDK5RAP2 gene rs12379034 polymorphisms was conducted using TaqMan
allelic discrimination (for rs12617656) and ARMS-PCR (for rs12379034) methods.
Results: Experiments demonstrated that alleles and genotypes of both SNPs were represented equally in
RA patients and controls. Statistical analysis revealed that none of the rs12617656 and rs12379034 SNPs
had significant differences in prevalence of both alleles and genotypes between RA patients and healthy
controls.
Conclusions: It appears that gene polymorphisms of DPP4 and CDK5RAP2 are not involved in the patho-
genesis of RA in Iranian population.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
RA is a chronic multifactorial disorder with involvement of the
small diarthrodial joints of the hands and feet. Both genetics and
environmental factors are the important contributing factors in
the pathogenesis of RA [1–4]. Recently, determining roles of genet-
ics in RA susceptibility have been explored mostly by genome-
wide association studies (GWAS). Human leukocyte antigen
(HLA) account for one-third of the genetic contributing factors
for RA pathogenesis in addition to non-HLA components, which
are increasingly being detected by genome-wide scannings [5].
DPP4 gene encodes dipeptidyl peptidase-4 (DPP4) or cluster of
differentiation 26 (CD26), which is a membranous glycoprotein
and is expressed on the surface of immune and non-immune cells
with enzymatic activity of cleaving proline containing dipeptides.
Its role has been clarified in some previous studies as an immune
regulator and its serum levels and cell surface form have been sur-
Table 1
Primers used in ARMS-PCR for CDK5RAP2 gene rs12379034 genotyping, amplicon size
and melting temperature of each reaction.
Primer Sequence Amplicon size (bp) Temp (C)
NF AGCTAGTCCATGAGGACAAATga 220 57.4
MF AGCTAGTCCATGAGGACAAATgg 220 57.4
RC CTTACTTGATCCGTCCCACA 220 58.5
Seq AGGAATCAGAAGGTCCAGAA 282 58.7
NF, Normal Forward primer; MF, Mutant Forward primer; RC, Reverse Common
primer; Seq, sequence primer.
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strong association of DPP4 gene rs12617656 SNP with RA risk
was demonstrated in a GWAS, indicating how genes can affect
RA proneness in Han Chinese populations [8]. We also hypothe-
sized that this polymorphism might take part in RA susceptibility
and possibly in the progression of the disease in Iranian
population.
Cyclin-dependent kinase 5 (CDK-5) regulatory subunit–associ-
ated protein 2 (CDK5RAP2) has an important role in differentiation
process of neuronal system by forming the microtubule nucleator
via gamma-tubulin ring complex recruitment to centrosomes [9].
This is a vital stage in brain evolution and mutations in the
attributed genes during brain development result in mitosis
division disturbance in neurons, culminating in microcephaly
[10]. Surprisingly, a GWAS detected a strong association of
rs12379034 SNP in CDK5RAP2 gene with the above-mentioned
function with RA susceptibility, introducing the association of a
neuronal-related gene with an autoimmune disease for the first
time [8].
Given the important roles of the DPP4 gene in RA predisposition
and how CDK5RAP2 acts in immune and neuronal systems of RA
patients, we were interested in surveying the possible connections
between the two mentioned polymorphisms in these genes and RA
risk in Iranian population.2. Subjects and methods
2.1. Patients and controls
Our study population was composed of 623 (524 females and
99 male) RA patients recruited from the Rheumatology Clinic of
Shariati Hospital and 412 (356 females and 56 male) healthy unre-
lated subjects without any history of autoimmune diseases. The RA
patients who met the 1997 revised American College of Rheuma-
tology (ACR) classification criteria [11] were delicately matched
with control group considering age, sex, and ethnicity. Alongside
genotyping of SNPs, phenotypical characteristics of RA patients
were obtained to investigate the relation between two polymor-
phisms and clinical features. Written inform consent was taken
by all the subjects and the protocol of this study was approved
by the Ethics Committee of Tehran University of Medical Sciences.
The work has been carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki)
for experiments in humans.2.2. Genotyping
Blood samples were taken from patients and healthy individu-
als into ethylenediaminetetraacetic acid (EDTA) containing tubes
and genomic DNA was extracted from peripheral leukocytes apply-
ing the phenol-chloroform method [12]. The extracted DNA was
stored at 20 C until the proper time for the experiments. Geno-
typing was performed using StepOnePlus Real-Time PCR System
and TaqMan MGB-based allelic discrimination method (both
Applied Biosystems, Foster City, CA, USA) for rs12617656 and
Amplification Refractory Mutation System-Polymerase Chain Reac-
tion (ARMS-PCR) for rs12379034. The ARMS-PCR technique [13] is
a precise and rapid method, detecting a specific SNP in a large
number of SNPs and is based on a mutation or mismatched nucleo-
tide(s) at 30 end of the primer. Three primers including two forward
(mutant and wild-type) and one reverse common primer (Table 1)
were designed by Primer 3 online tool (http://primer3.ut.ee). The
ARMS-PCR was conducted in a 15 lL reaction containing 2 lL
DNA template, 5U Taq DNA polymerase (SinaClon, Iran), 2.5 lL
10 PCR buffer (SinaClon, Iran), 0.25 lL 10 mM dNTP (SinaClon,Iran) and 1 lL of each specific primer (10 pmol/lL). Two internal
control primers with 0.12 lL volume in each reaction was also
utilized. The following primers were used as internal control, for-
ward: 50 TGCTCAGCCAGTTTGACTTA 30 and reverse: 50 CCTGCAGG-
TATATTTTGGCG 30. PCR was performed as follow: an initial
denaturation at 94 C for 3 min, 40 cycles for DNA amplification
consist of 30 s at 94 C, 30 s at 63.6 C, 30 s 72 C and a final exten-
sion at 72 C for 10 min. PCR products were electrophoresed in 2%
agarose gel stained with DNA safe staining (SinaClon, Iran) and
were observed through UV transilluminator (Fig. 1). We chose a
few samples for sequencing to confirm the accuracy of the ampli-
fication (Fig. 2).
To perform TaqMan MGB-based allelic discrimination, all PCR
reactions mixture contained approximately 25–75 ng of DNA,
5 lL Taq-Man Master Mix containing Taq DNA polymerase and
dNTPs (Applied Biosystems, Foster City, USA), 0.25 lL Taq-Man
Genotyping Assay mix containing primers and FAM or VIC labeled
probes (Applied Biosystems, Foster City, USA), and distilled water
for a final volume of 10 lL. Thermocyclic conditions of PCR were:
initially 60 C for 30 s and then 95 C for 10 min, and subsequently
40 cycles of amplification (95 C for 15 s and 60 C for 1 min), and
finally 60 C for 30 s.
2.3. Statistical analysis
All statistical analyses were performed using SPSS, version 21
(IBM Inc, Chicago, IL, USA). The generalized linear model (i.e. logis-
tic regression) and chi-square tests were used to evaluate the asso-
ciation of alleles and genotypes of SNPs with disease status and
clinical manifestations, respectively. Odds ratios (ORs) as the effect
size with 95% confidence intervals (95% CI) were calculated in each
group. The control group was evaluated for Hardy–Weinberg
Equilibrium (HWE) in each locus using SHEsis online tool [14]. P
values less than 0.05 were considered as statistically significant.
3. Results
Demographic and laboratory information of RA patients and
healthy controls are shown in Table 2.
The genotype distribution of DPP4 gene rs12617656 and
CDK5RAP2 gene rs12379034 SNPs in the healthy controls demon-
strated no significant deviation from the HWE (P = 0.124 and
0.256, respectively). As shown in Table 3, the global major allele
of T was regarded as the reference allele for rs12617656 SNP
according to NCBI database. The C allele of rs12617656 SNP was
distributed almost equally between patients and controls (33.7%
vs. 32.4%). Therefore, this allele had no significantly different distri-
bution between RA patients and healthy controls (OR = 0.95, CI:
0.74–1.23; P = 0.74). On the other side, considering the TT
genotype as the reference, genotypes of rs12617656 SNP did not
represent significantly different prevalence between cases and
controls. The CT genotype of this SNP was less represented in RA
patients in comparison to healthy subjects (43.5% vs. 46.1%);
hence the difference was not statistically significant (OR = 0.90,
Fig. 1. Genotyping models of rs12379034 SNP in CKD5RAP2 gene obtained from ARMS-PCR implementations. First line depicts the internal control with 367 bp product size.
The second line illustrated DNA bands of with 220 bp of size. For homozygous samples, there is one 220 bp band, while two 220 bp bands are seen for heterozygous samples.
From right to left, the first one is for mutant allele and the second is for wild-type DNA. DNA ladder and No template control (NTC) are also depicted.
Fig. 2. Sequencing analysis of ARMS-PCR products of CDK5RAP2 gene rs12379034 SNP in a patient, demonstrating the A allele. The results of sequencing were in accordance
with agarose gel electrophoresis of ARMS-PCR products.
Table 2
Demographic data and laboratory specifications of RA patients and healthy controls.
Characteristic RA patients
(n = 623) N (%)
Healthy individuals
(n = 412) N (%)
Male 99 (16%) 56 (13.5%)
Female 524 (84%) 356 (86.5%)
Age 50.32 ± 12.05* 42.69 ± 12.64
RF 82.23 ± 97.14 –
Anti-CCP 129.91 ± 219.83 –
DAS28 2.92 ± 1.2 –
ESR 17.98 ± 15.53 –
RA, Rheumatoid Arthritis; RF, Rheumatoid Factor; anti-CCP, anti-Cyclic Citrullinated
Peptide Antibody; DAS28, Disease Activity Score for 28 Joints; ESR, Erythrocyte
Sedimentation Rate.
* Data are represented as Mean ± Standard Deviation.
Table 3
Allele and genotype frequencies of DPP4 gene rs12617656 and CDK5RAP2 gene rs1237903

















AG + GG 211 (33.9)
HWE
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ently distributed between cases and controls. As the dominant
genotype, the CC + CT pattern did not show significantly different
prevalence between RA cases and healthy controls.
On the other hand, the A allele of rs12379034 SNP was sup-
posed as the reference allele (Table 3). The G allele of this SNP
demonstrated the same frequency in cases and controls with
insignificant difference (OR = 1.05, CI: 0.83–1.31; P = 0.67). The
AA genotype of rs12379034 SNP was considered as the reference
genotype. The AG genotype of this SNP was more frequent in RA
patients than in controls (30.4% vs. 27.7%); however, the difference
was not significant (OR = 1.24, CI: 0.95–1.61; P = 0.11). Despite the
GG genotype was more frequent in healthy subjects, the preva-
lence difference was not statistically significant. The AG + GG
model was the dominant genotype and it was expressed more4 SNPs in RA patients and healthy controls.
Control (n = 412) N (%) P OR (95% CI)
557 (67.6) Reference –
267 (32.4) 0.74 0.95 (.74–1.23)
182 (44.2) Reference –
190 (46.1) 0.59 0.90 (0.63–1.29)
40 (9.7) 0.94 0.97 (0.54–1.77)
230 (55.9) 0.63 0.92 (0.65–1.29)
P = 0.124
676 (82) Reference –
148 (18) 0.67 1.05 (0.83–1.31)
281 (68.2) Reference –
114 (27.7) 0.11 1.24 (0.95–1.61)
17 (4.1) 0.23 0.66 (0.33–1.31)
131 (31.8) 0.09 1.26 (0.96–1.64)
P = 0.256
Table 4








RF 44.25 ± 41.31 95.01 ± 114.09 76.61 ± 87.222 0.173
Anti-CCP 270.2 ± 329.81 146.1 ± 240.4 113.51 ± 198.31 0.093
DAS28 3.36 ± 0.81 2.71 ± 1.01 3 ± 1.29 0.129








RF 93.76 ± 115.73 76.07 ± 88.62 82.21 ± 96.87 0.663
Anti-CCP 100.98 ± 120.28 124.21 ± 214.23 151.03 ± 250.65 0.468
DAS28 3.08 ± 1.16 2.97 ± 1.14 2.84 ± 1.21 0.612
ESR 19.78 ± 14.06 17.56 ± 13.61 19.12 ± 17.43 0.607
RA, Rheumatoid Arthritis; RF, Rheumatoid Factor; Anti-CCP, Anti-Cyclic Citrullinated Peptide Antibody; DAS28, Disease Activity Score for 28 Joints; ESR, Erythrocyte
Sedimentation Rate.
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(33.9% vs. 31.88), in spite of insignificant difference (OR = 1.26,
CI: 0.96–1.64; P = 0.09).
No significant correlations were observed between the geno-
types of DPP4 gene rs12617656 and CDK5RAP2 gene rs12379034
SNPs and clinical data of RA patients (Table 4). Evaluated clinical
data comprised of ESR (Erythrocyte sedimentation rate), DAS28
(Disease Activity Score in 28 Joints), RF (Rheumatoid factor), and
anti-CCP (anti-Cyclic Citrullinated Peptide Antibody).4. Discussion
Numerous studies have indicated that genetic factors play an
important role and are responsible for about 60% of susceptibility
and clinical outcomes of RA disease [15]. The association of RA
with the HLA-DRB1 gene is the well understood genetic association.
However, many non-HLA loci have been associated with RA, such
as the TNFRSR11A gene, which encodes the receptor activator of
nuclear factor jB (RANK), playing an important role in bone
resorption in RA [16]. On the other side, genetic factors are fruitful
in the treatment of RA due to the activity of enzymes involved in
the metabolism of drugs like azathioprine, methotrexate,
methylenetetrahydrofolate reductase, and thiopurine methyltrans-
ferase, which are involved in modulation of genetic-caused mani-
festations [17,18].
DPP4 gene encodes DPP4 enzyme, also known as cell surface
antigen CD26, which have serine protease activity and is involved
in cleaving of a number of regulatory factors, such as growth fac-
tors and chemokines [19]. Agents with inhibitory action on DPP4
have recently been introduced as novel pharmacological com-
pounds for treatment of inflammatory disease [20]. It has been
shown that DPP4 was up-regulated in active RA patients [21].
DPP4 play an important role in T cell co-stimulation. The CD4+
interleukin-17 producing T helper (Th) 17 cells play an important
role in inflammation and seem to be involved in RA disease pro-
gression [22]. DPP4 is highly expressed on Th17 cells in compar-
ison to other subsets of CD4+ T lymphocyte. This molecule
impresses on the chemotaxis of T cells through cleaving the proin-
flammatory chemokines such as CXCL9, CXCL10, CXCL11, and
CXCL12 [23]. Association of DDP4 gene rs12617656 SNP with
increased risk of RA was first described in Han Chinese population.
Furthermore, rs12617656 demonstrated a strong interaction effect
with anti–citrullinated protein antibody (ACPA) [8]. Later, the asso-
ciation of this SNP was observed with increased risk of type 1 dia-
betes (T1D) in Malaysian population and related to serum DPP4
levels [24]. In this study, the DPP4 gene rs12617656 SNP was eval-
uated in relation to RA risk in Iranian population. It was observed
that rs12617656 polymorphism in DPP4 gene was not a genetically
contributing factor for RA susceptibility. The disparity in geneticassociation studies is common and usually attributed to differ-
ences in techniques, sample size, power of the study, ethnicity,
and even environmental factors that individuals experience during
life time.
First GWAS of RA patients in Han Chinese population demon-
strated strong association of rs12379034 SNP, located in the coding
region of CDK5RAP2 gene, with susceptibility to the disease. More-
over, CDK5RAP2 gene demonstrated connection with two genes,
KIF23 and FGFR1OP, which already were associated with RA risk
in European population [8]. CDK5RAP2 has been implicated to par-
ticipate in the modulation of neuronal differentiation pathway
[25]. However, no study has suggested that CDK5RAP2 might play
role in the pathogenesis of autoimmune disorders, including RA.
Nonetheless, the strong association of CDK5RAP2 gene
rs12379034 SNP with increased RA risk as well as its connection
with other RA associated genes imply to new pathway in the
pathogenesis of the disease. Investigation of possible connection
between CDK5RAP2 gene rs12379034 SNP in Iranian population
revealed that this variant could not impress the risk of RA. How-
ever, further analyses of CDK5RAP2 gene for other SNPs might con-
tribute our understanding of novel pathogenesis pathway of RA
with emphasis on neuronal differentiation perspective.
5. Conclusion
Considering all the facts, this was the first replicated study of
DPP4 gene rs12617656 and CDK5RAP2 rs12379034 polymorphisms
in Iranian RA population. None of these variants could impress the
RA risk and could not be considered as the genetic contributing fac-
tor for the disease susceptibility. However, further investigations
will be helpful in gaining clear knowledge of RA pathogenesis with
respect of DPP4 and CDK5RAP2 genes.
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